课题基金 / 基金详情

NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY

NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍的神经生物学和光疗法
批准号:
3859875
负责人:
D A OREN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

D A OREN的其他基金

相似基金

相关文献

中文摘要
翻译
光对冬季SAD的作用机制及其生物学效应 引起该综合征的异常尚不清楚。 我们一直在追求 SAD的病理生理学有沿着三条线:眼睛、神经内分泌 基因图谱和免疫生物学 确认SAD患者是否 对光的感知超敏感,正如我们可能已经展示的那样,我们评估了 用Goldmann/Weekers适应计对25例患者进行暗适应检查 和25名年龄和性别匹配的对照组。 我们发现, 两组 Depue和其他人已经确定多巴胺是一种 季节性情感障碍(SAD)的研究兴趣的神经递质。 对动物的研究已经证实,多巴胺是 神经递质在脊椎动物视网膜和视网膜的生产 多巴胺受到光的刺激,受到视网膜产生的 褪黑素 为了评估视网膜多巴胺能机制,我们 在SAD患者和非SAD患者中检查视网膜电图和眨眼率。 正常对照组在用左旋多巴加卡比多巴治疗之前和之后。 图形视网膜电图显示, 治疗前或治疗后的患者和对照组。 眼部分析 眨眼率在患者和对照组之间也没有差异。 尽管如此,早晨的光线处理显著降低了眨眼率, 绝经前女性 这一发现特别有意义, 发现SAD患者多巴胺能失调证据的研究人员 专门研究绝经前妇女。 我们计划继续我们的 可能与眼睛相关的多巴胺能异常的研究, 对冬季SAD患者和正常志愿者进行眼电图检查。 我们对冬季SAD患者神经内分泌功能的研究表明, 这种光纠正了这种异常。 我们继续以前的工作, SAD组与对照组免疫功能比较 对照组,但我们无法确定组间差异 或者任何光疗法改变免疫参数的证据
英文摘要
The mechanism of action of light for winter SAD and the biological abnormalities responsible for the syndrome are unknown. We have pursued the pathophysiology of SAD along three lines: the eye, neuroendocrine profiles, and immunobiology. To confirm whether patients with SAD are supersensitive to perceiving light, as we have probably shown, we evaluated dark adaptation by means of a Goldmann/Weekers Adaptometer on 25 patients and 25 age- and sex-matched controls. We found no difference between the two groups. Depue and others have identified dopamine as a neurotransmitter of research interest in seasonal affective disorder (SAD). Research in animals has established that dopamine is the major neurotransmitter in the vertebrate retina and that production of retinal dopamine is stimulated by light and suppressed by retinally-produced melatonin. To assess retinal dopaminergic mechanisms in particular, we examined electroretinograms and eye blink rates in SAD patients and in normal controls both before and after treatment with L-dopa plus carbidopa. Pattern electroretinograms showed no significant difference between patients and controls either before or after treatment. Analysis of eye blink rates also showed no differences between patients and controls. Nevertheless, morning light treatment significantly reduced eye blink rate in premenopausal females. This finding is of particular interest given that the researcher who found evidence of dopaminergic dysregulation in SAD exclusively studied premenopausal women. We plan to continue our investigation of possible eye-related dopaminergic abnormalities by performing electrooculograms on winter SAD patients and normal volunteers. Our investigations of neuroendocrine functioning in winter SAD have shown that light corrects this abnormality. We continued previous work of our group comparing immunological function among SAD patients and matched controls, but we were unable to establish any difference between the groups or any evidence of light therapy changing immune parameters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLOGICAL FINDINGS IN HYPERNYCHTHEMERAL SYNDROME
LIGHT AND THE EYE IN WINTER SEASONAL AFFECTIVE DISORDER
NOVEL TREATMENT MODALITIES FOR SAD
海外基金